129 related articles for article (PubMed ID: 37300942)
41. Progress in research and development of temozolomide brain-targeted preparations: a review.
Yang J; Xu Y; Fu Z; Chen J; Fan W; Wu X
J Drug Target; 2023 Feb; 31(2):119-133. PubMed ID: 36039767
[TBL] [Abstract][Full Text] [Related]
42. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells.
Yan F; Li X; Jin Q; Jiang C; Zhang Z; Ling T; Qiu B; Zheng H
Ultrasound Med Biol; 2011 May; 37(5):768-79. PubMed ID: 21458148
[TBL] [Abstract][Full Text] [Related]
44. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
Jun HY; Park SH; Kim HS; Yoon KH
Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
[TBL] [Abstract][Full Text] [Related]
45. Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.
Belter A; Barciszewski J; Barciszewska AM
PLoS One; 2020; 15(2):e0229534. PubMed ID: 32101575
[TBL] [Abstract][Full Text] [Related]
46. Brain Delivery of Cisplatin Using Microbubbles in Combination with Ultrasound as an Effective Therapy for Glioblastoma.
Hagiwara F; Omata D; Munakata L; Kageyama S; Maruyama K; Kudo N; Suzuki R
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004464
[TBL] [Abstract][Full Text] [Related]
47. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
48. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
[TBL] [Abstract][Full Text] [Related]
49. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging.
Liao AH; Li YK; Lee WJ; Wu MF; Liu HL; Kuo ML
Ultrasound Med Biol; 2012 Nov; 38(11):1938-48. PubMed ID: 22929655
[TBL] [Abstract][Full Text] [Related]
50. Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.
Lu G; Zhu P; Rao M; Linendoll N; Buja LM; Bhattacharjee MB; Brown RE; Ballester LY; Tian X; Pilichowska M; Wu JK; Hergenroeder GW; Glass WF; Chen L; Zhang R; Pillai AK; Hunter RL; Zhu JJ
J Neurooncol; 2022 Oct; 160(1):221-231. PubMed ID: 36203027
[TBL] [Abstract][Full Text] [Related]
51. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
52. Engineered microbubbles decorated with red emitting carbon nanoparticles for efficient delivery and imaging.
Guduru AT; Mansuri A; Singh U; Kumar A; Bhatia D; Dalvi SV
Biomater Adv; 2024 Jul; 161():213886. PubMed ID: 38735200
[TBL] [Abstract][Full Text] [Related]
53. Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems.
Petrenko D; Chubarev V; Syzrantsev N; Ismail N; Merkulov V; Sologova S; Grigorevskikh E; Smolyarchuk E; Alyautdin R
Molecules; 2022 May; 27(11):. PubMed ID: 35684445
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells.
Shi F; Yang F; He X; Zhang Y; Wu S; Li M; Zhang Y; Di W; Dou J; Gu N
J Drug Target; 2016; 24(1):34-46. PubMed ID: 26204324
[TBL] [Abstract][Full Text] [Related]
55. Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.
Han S; Meng L; Jiang Y; Cheng W; Tie X; Xia J; Wu A
Br J Cancer; 2017 May; 116(10):1302-1311. PubMed ID: 28359080
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
57. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
58. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
59. Next generation ultrasound platforms for theranostics.
Oddo L; Cerroni B; Domenici F; Bedini A; Bordi F; Chiessi E; Gerbes S; Paradossi G
J Colloid Interface Sci; 2017 Apr; 491():151-160. PubMed ID: 28024192
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
